{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T12:08:42Z","timestamp":1790338122090,"version":"4.1.0"},"reference-count":194,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T00:00:00Z","timestamp":1774396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000892","name":"Prostate Cancer Foundation","doi-asserted-by":"publisher","award":["25YOUN19"],"award-info":[{"award-number":["25YOUN19"]}],"id":[{"id":"10.13039\/100000892","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020400","name":"Weill Cornell Medicine Clinical and Translational Science Center","doi-asserted-by":"publisher","award":["TR0002387-07"],"award-info":[{"award-number":["TR0002387-07"]}],"id":[{"id":"10.13039\/100020400","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society Inc","doi-asserted-by":"publisher","award":["PF-24-1318851-01-MM"],"award-info":[{"award-number":["PF-24-1318851-01-MM"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005410","name":"American-Italian Cancer Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005410","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P50CA211024"],"award-info":[{"award-number":["P50CA211024"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["P01CA265768"],"award-info":[{"award-number":["P01CA265768"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020581","name":"AIRC Foundation for Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020581","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gene"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.gene.2026.150131","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:41:08Z","timestamp":1774658468000},"page":"150131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)"],"prefix":"10.1016","volume":"996","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3873-7465","authenticated-orcid":false,"given":"Filippo","family":"Pederzoli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Pakula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Garner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Vitale","family":"Nuzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bleve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Rickman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe Nicol\u00f2","family":"Fanelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Loda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.gene.2026.150131_b0005","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1111\/j.1432-0436.2008.00292.x","article-title":"Integrating differentiation and cancer: the Nkx3.1 homeobox gene in prostate organogenesis and carcinogenesis","volume":"76","author":"Abate-Shen","year":"2008","journal-title":"Differentiation"},{"key":"10.1016\/j.gene.2026.150131_b0010","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1128\/MCB.22.5.1495-1503.2002","article-title":"Conditional loss of Nkx3.1 in adult mice induces prostatic intraepithelial neoplasia","volume":"22","author":"Abdulkadir","year":"2002","journal-title":"Mol. Cell Biol."},{"key":"10.1016\/j.gene.2026.150131_b0015","article-title":"A prospective investigation of PTEN loss and ERG expression in lethal prostate cancer","volume":"108","author":"Ahearn","year":"2016","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.gene.2026.150131_b0020","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1158\/1940-6207.CAPR-24-0085","article-title":"The past and future of angiogenesis as a target for cancer therapy and prevention","volume":"17","author":"Albini","year":"2024","journal-title":"Cancer Prev. Res. (Phila.)"},{"key":"10.1016\/j.gene.2026.150131_b0025","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI40535","article-title":"A novel type of cellular senescence that can be enhanced in mouse models and human tumor xenografts to suppress prostate tumorigenesis","volume":"120","author":"Alimonti","year":"2010","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150131_b0030","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/j.celrep.2014.01.013","article-title":"Destruction of full-length androgen receptor by wild-type SPOP, but not prostate-cancer-associated mutants","volume":"6","author":"An","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0035","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1172\/JCI58540","article-title":"Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis","volume":"122","author":"Anderson","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150131_b0040","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0000000000000205","article-title":"Utility of ERG versus AMACR expression in diagnosis of minimal adenocarcinoma of the prostate in needle biopsy tissue","volume":"38","author":"Andrews","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0045","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1038\/s43018-020-00125-0","article-title":"A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance","volume":"1","author":"Arriaga","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.gene.2026.150131_b0050","doi-asserted-by":"crossref","first-page":"E3506","DOI":"10.1073\/pnas.1303558110","article-title":"ETV4 promotes metastasis in response to activation of PI3-kinase and Ras signaling in a mouse model of advanced prostate cancer","volume":"110","author":"Aytes","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0055","doi-asserted-by":"crossref","first-page":"5201","DOI":"10.1038\/s41467-018-07511-4","article-title":"NSD2 is a conserved driver of metastatic prostate cancer progression","volume":"9","author":"Aytes","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0060","doi-asserted-by":"crossref","DOI":"10.1016\/j.gene.2025.149774","article-title":"Therapy-induced senescence in prostate cancer: mechanisms, therapeutic strategies, and clinical implications","volume":"972","author":"Bacca","year":"2025","journal-title":"Gene"},{"key":"10.1016\/j.gene.2026.150131_b0065","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1101\/gad.211011.112","article-title":"ETV1 directs androgen metabolism and confers aggressive prostate cancer in targeted mice and patients","volume":"27","author":"Baena","year":"2013","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150131_b0070","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ebiom.2017.04.006","article-title":"c-Myc antagonises the transcriptional activity of the androgen receptor in prostate cancer affecting key gene networks","volume":"18","author":"Barfeld","year":"2017","journal-title":"EBioMedicine"},{"key":"10.1016\/j.gene.2026.150131_b0075","doi-asserted-by":"crossref","first-page":"3504","DOI":"10.1016\/j.celrep.2018.11.069","article-title":"Single-cell analysis identifies LY6D as a marker linking castration-resistant prostate luminal cells to prostate progenitors and cancer","volume":"25","author":"Barros-Silva","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0080","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/path.5587","article-title":"Genetic ablation of FASN attenuates the invasive potential of prostate cancer driven by Pten loss","volume":"253","author":"Bastos","year":"2021","journal-title":"J. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0085","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/2159-8290.CD-11-0130","article-title":"Molecular characterization of neuroendocrine prostate cancer and identification of new drug targets","volume":"1","author":"Beltran","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2026.150131_b0090","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/j.eururo.2014.02.058","article-title":"ERG protein expression in diagnostic specimens is associated with increased risk of progression during active surveillance for prostate cancer","volume":"66","author":"Berg","year":"2014","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0095","doi-asserted-by":"crossref","first-page":"3924","DOI":"10.1172\/JCI127961","article-title":"N-Myc-mediated epigenetic reprogramming drives lineage plasticity in advanced prostate cancer","volume":"129","author":"Berger","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150131_b0100","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.canlet.2021.12.024","article-title":"SPOP-mutant prostate cancer: translating fundamental biology into patient care","volume":"529","author":"Bernasocchi","year":"2022","journal-title":"Cancer Lett."},{"key":"10.1016\/j.gene.2026.150131_b0105","doi-asserted-by":"crossref","first-page":"36442","DOI":"10.1074\/jbc.M504945200","article-title":"Expression signature of the mouse prostate","volume":"280","author":"Berquin","year":"2005","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.gene.2026.150131_b0110","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1101\/gad.13.8.966","article-title":"Roles for Nkx3.1 in prostate development and cancer","volume":"13","author":"Bhatia-Gaur","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150131_b0115","article-title":"Lipid metabolism and cancer","volume":"218","author":"Bian","year":"2020","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.gene.2026.150131_b0120","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1593\/neo.131704","article-title":"SPOP mutations in prostate cancer across demographically diverse patient cohorts","volume":"16","author":"Blattner","year":"2014","journal-title":"Neoplasia"},{"key":"10.1016\/j.gene.2026.150131_b0125","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.ccell.2017.02.004","article-title":"SPOP mutation drives prostate tumorigenesis in vivo through coordinate regulation of PI3K\/mTOR and AR signaling","volume":"31","author":"Blattner","year":"2017","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0130","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1158\/0008-5472.CAN-23-0519","article-title":"Obesogenic high-fat diet and MYC cooperate to promote lactate accumulation and tumor microenvironment remodeling in prostate cancer","volume":"84","author":"Boufaied","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/nature04733","article-title":"Polycomb complexes repress developmental regulators in murine embryonic stem cells","volume":"441","author":"Boyer","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0140","doi-asserted-by":"crossref","first-page":"3372","DOI":"10.1038\/s41467-021-23780-y","article-title":"Temporal evolution of cellular heterogeneity during the progression to advanced AR-negative prostate cancer","volume":"12","author":"Brady","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0145","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1158\/1541-7786.MCR-23-0411","article-title":"Updating the definition of cancer","volume":"21","author":"Brown","year":"2023","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0150","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.addr.2020.07.013","article-title":"Lipids and cancer: Emerging roles in pathogenesis, diagnosis and therapeutic intervention","volume":"159","author":"Butler","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.gene.2026.150131_b0155","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1038\/ng.370","article-title":"Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate","volume":"41","author":"Carver","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0160","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.ccr.2011.04.008","article-title":"Reciprocal feedback regulation of PI3K and androgen receptor signaling in PTEN-deficient prostate cancer","volume":"19","author":"Carver","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0165","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2353\/ajpath.2006.050443","article-title":"Differential sensitivity of mouse epithelial tissues to the polyomavirus middle T oncogene","volume":"168","author":"Cecena","year":"2006","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0170","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1097\/PAS.0b013e31821e8761","article-title":"Immunohistochemistry for ERG expression as a surrogate for TMPRSS2-ERG fusion detection in prostatic adenocarcinomas","volume":"35","author":"Chaux","year":"2011","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0175","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/nm.3216","article-title":"ETS factors reprogram the androgen receptor cistrome and prime prostate tumorigenesis in response to PTEN loss","volume":"19","author":"Chen","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2026.150131_b0180","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41588-017-0026-3","article-title":"Compartmentalized activities of the pyruvate dehydrogenase complex sustain lipogenesis in prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0185","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nature03918","article-title":"Crucial role of p53-dependent cellular senescence in suppression of Pten-deficient tumorigenesis","volume":"436","author":"Chen","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0190","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/s41588-017-0027-2","article-title":"An aberrant SREBP-dependent lipogenic program promotes metastatic prostate cancer","volume":"50","author":"Chen","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0195","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2353\/ajpath.2008.070602","article-title":"Dissociation of epithelial and neuroendocrine carcinoma lineages in the transgenic adenocarcinoma of mouse prostate model of prostate cancer","volume":"172","author":"Chiaverotti","year":"2008","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0200","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1158\/2159-8290.CD-13-0346","article-title":"RapidCaP, a novel GEM model for metastatic prostate cancer analysis and therapy, reveals myc as a driver of Pten-mutant metastasis","volume":"4","author":"Cho","year":"2014","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2026.150131_b0205","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2427116122","article-title":"Cellular cartography reveals mouse prostate organization and determinants of castration resistance","volume":"122","author":"Cho","year":"2025","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0210","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1210\/mend.11.9.9974","article-title":"A 6-kb promoter fragment mimics in transgenic mice the prostate-specific and androgen-regulated expression of the endogenous prostate-specific antigen gene in humans","volume":"11","author":"Cleutjens","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.gene.2026.150131_b0215","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1210\/mend.11.2.9883","article-title":"An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter","volume":"11","author":"Cleutjens","year":"1997","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.gene.2026.150131_b0220","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.1158\/1078-0432.CCR-21-4289","article-title":"Therapeutic implications for intrinsic phenotype classification of metastatic castration-resistant prostate cancer","volume":"28","author":"Coleman","year":"2022","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0225","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.ccell.2025.05.015","article-title":"Senescence in cancer","volume":"43","author":"Colucci","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0230","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/s41585-024-00991-8","article-title":"Prostate cancer epigenetics - from pathophysiology to clinical application","volume":"22","author":"Const\u00e2ncio","year":"2025","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0235","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.diff.2008.09.010","article-title":"Simultaneous haploinsufficiency of Pten and Trp53 tumor suppressor genes accelerates tumorigenesis in a mouse model of prostate cancer","volume":"77","author":"Couto","year":"2009","journal-title":"Differentiation"},{"key":"10.1016\/j.gene.2026.150131_b0240","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1097\/PAP.0000000000000205","article-title":"Immunohistochemical Pitfalls in Genitourinary Pathology: 2018 Update","volume":"25","author":"Cox","year":"2018","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.gene.2026.150131_b0245","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1016\/j.celrep.2019.07.007","article-title":"Expansion of luminal progenitor cells in the aging mouse and human prostate","volume":"28","author":"Crowell","year":"2019","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0250","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2023.113221","article-title":"MYC is a regulator of androgen receptor inhibition-induced metabolic requirements in prostate cancer","volume":"42","author":"Crowell","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0255","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.59465","article-title":"A single-cell atlas of the mouse and human prostate reveals heterogeneity and conservation of epithelial progenitors","volume":"9","author":"Crowley","year":"2020","journal-title":"Elife"},{"key":"10.1016\/j.gene.2026.150131_b0260","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1210\/edrv-8-3-338","article-title":"The endocrinology and developmental biology of the prostate","volume":"8","author":"Cunha","year":"1987","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.gene.2026.150131_b0265","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1016\/j.ccell.2016.09.005","article-title":"N-Myc induces an EZH2-mediated transcriptional program driving neuroendocrine prostate cancer","volume":"30","author":"Dardenne","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0270","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/nrurol.2018.22","article-title":"Cellular plasticity and the neuroendocrine phenotype in prostate cancer","volume":"15","author":"Davies","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0275","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1038\/s41556-021-00743-5","article-title":"An androgen receptor switch underlies lineage infidelity in treatment-resistant prostate cancer","volume":"23","author":"Davies","year":"2021","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.gene.2026.150131_b0280","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1038\/sj.onc.1210237","article-title":"TMPRSS2:ERG gene fusion associated with lethal prostate cancer in a watchful waiting cohort","volume":"26","author":"Demichelis","year":"2007","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150131_b0285","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1038\/s41571-021-00549-2","article-title":"The MYC oncogene - the grand orchestrator of cancer growth and immune evasion","volume":"19","author":"Dhanasekaran","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150131_b0290","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1038\/1235","article-title":"Pten is essential for embryonic development and tumour suppression","volume":"19","author":"Di Cristofano","year":"1998","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0295","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nature09677","article-title":"SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression","volume":"470","author":"Ding","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0300","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.cell.2012.01.039","article-title":"Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases","volume":"148","author":"Ding","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0305","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1158\/1541-7786.MCR-24-0105","article-title":"Y chromosome loss and implications for oncology","volume":"22","author":"Dirican","year":"2024","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0310","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/356215a0","article-title":"Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours","volume":"356","author":"Donehower","year":"1992","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0315","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1101\/gad.13.20.2658","article-title":"Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis","volume":"13","author":"Eischen","year":"1999","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150131_b0320","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/1097-0029(20001201)51:5<436::AID-JEMT6>3.0.CO;2-T","article-title":"Unique features of the basal cells of human prostate epithelium","volume":"51","author":"El-Alfy","year":"2000","journal-title":"Microsc. Res. Tech."},{"key":"10.1016\/j.gene.2026.150131_b0325","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/pros.20071","article-title":"Transgenic mouse with human mutant p53 expression in the prostate epithelium","volume":"61","author":"Elgavish","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0330","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S1535-6108(03)00197-1","article-title":"Myc-driven murine prostate cancer shares molecular features with human prostate tumors","volume":"4","author":"Ellwood-Yen","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.path.2024.10.003","article-title":"Deciphering complexity: the molecular landscape of castration-resistant prostate cancer","volume":"18","author":"Fanelli","year":"2025","journal-title":"Surg. Pathol. Clin."},{"key":"10.1016\/j.gene.2026.150131_b0340","doi-asserted-by":"crossref","first-page":"10887","DOI":"10.1073\/pnas.93.20.10887","article-title":"Ligand-activated site-specific recombination in mice","volume":"93","author":"Feil","year":"1996","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0345","doi-asserted-by":"crossref","first-page":"4483","DOI":"10.1158\/0008-5472.CAN-12-0283","article-title":"Dual targeting of the Akt\/mTOR signaling pathway inhibits castration-resistant prostate cancer in a genetically engineered mouse model","volume":"72","author":"Floc'h","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0350","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.ccell.2024.09.010","article-title":"The hallmarks of cancer immune evasion","volume":"42","author":"Galassi","year":"2024","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0355","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1158\/1541-7786.MCR-21-0322","article-title":"Blocking PI3K p110\u03b2 attenuates development of PTEN-deficient castration-resistant prostate cancer","volume":"20","author":"Gao","year":"2022","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0360","doi-asserted-by":"crossref","first-page":"5631","DOI":"10.1158\/0008-5472.CAN-14-0476","article-title":"Androgen receptor is the key transcriptional mediator of the tumor suppressor SPOP in prostate cancer","volume":"74","author":"Geng","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0365","doi-asserted-by":"crossref","first-page":"4767","DOI":"10.1038\/onc.2017.80","article-title":"SPOP regulates prostate epithelial cell proliferation and promotes ubiquitination and turnover of c-MYC oncoprotein","volume":"36","author":"Geng","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150131_b0370","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1177\/019262339602400414","article-title":"A transgenic mouse prostate cancer model","volume":"24","author":"Gingrich","year":"1996","journal-title":"Toxicol. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0375","first-page":"4096","article-title":"Metastatic prostate cancer in a transgenic mouse","volume":"56","author":"Gingrich","year":"1996","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0380","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sj.pcan.4500296","article-title":"Pathologic progression of autochthonous prostate cancer in the TRAMP model","volume":"2","author":"Gingrich","year":"1999","journal-title":"Prostate Cancer Prostatic Dis."},{"key":"10.1016\/j.gene.2026.150131_b0385","doi-asserted-by":"crossref","first-page":"20882","DOI":"10.1073\/pnas.0811411106","article-title":"Trop2 identifies a subpopulation of murine and human prostate basal cells with stem cell characteristics","volume":"105","author":"Goldstein","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0390","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1634\/stemcells.2005-0585","article-title":"Proximal prostatic stem cells are programmed to regenerate a proximal-distal ductal axis","volume":"24","author":"Goto","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.gene.2026.150131_b0395","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1002\/pros.24460","article-title":"Single-cell atlas of epithelial and stromal cell heterogeneity by lobe and strain in the mouse prostate","volume":"83","author":"Graham","year":"2023","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0400","doi-asserted-by":"crossref","first-page":"7414","DOI":"10.1038\/s41467-024-51450-2","article-title":"Convergent alterations in the tumor microenvironment of MYC-driven human and murine prostate cancer","volume":"15","author":"Graham","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0405","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1078-1439(97)82844-X","article-title":"Transgenic models for prostate cancer research","volume":"2","author":"Greenberg","year":"1996","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.gene.2026.150131_b0410","first-page":"230","article-title":"The rat probasin gene promoter directs hormonally and developmentally regulated expression of a heterologous gene specifically to the prostate in transgenic mice","volume":"8","author":"Greenberg","year":"1994","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.gene.2026.150131_b0415","doi-asserted-by":"crossref","first-page":"3439","DOI":"10.1073\/pnas.92.8.3439","article-title":"Prostate cancer in a transgenic mouse","volume":"92","author":"Greenberg","year":"1995","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0420","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/modpathol.2012.206","article-title":"Cysteine-rich secretory protein 3 overexpression is linked to a subset of PTEN-deleted ERG fusion-positive prostate cancers with early biochemical recurrence","volume":"26","author":"Grupp","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0425","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41588-020-0642-1","article-title":"Single-cell transcriptomics identifies a distinct luminal progenitor cell type in distal prostate invagination tips","volume":"52","author":"Guo","year":"2020","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0430","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1038\/modpathol.2008.111","article-title":"Nuclear MYC protein overexpression is an early alteration in human prostate carcinogenesis","volume":"21","author":"Gurel","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0435","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1038\/modpathol.2009.69","article-title":"Fluorescence in situ hybridization study shows association of PTEN deletion with ERG rearrangement during prostate cancer progression","volume":"22","author":"Han","year":"2009","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0440","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110595","article-title":"Mesenchymal and stem-like prostate cancer linked to therapy-induced lineage plasticity and metastasis","volume":"39","author":"Han","year":"2022","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0445","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","article-title":"Hallmarks of cancer: new dimensions","volume":"12","author":"Hanahan","year":"2022","journal-title":"Cancer Discov."},{"key":"10.1016\/j.gene.2026.150131_b0450","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2025.12.049","article-title":"Hallmarks of cancer-then and now, and beyond","author":"Hanahan","year":"2026","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0455","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0460","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0465","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1046\/j.1432-0436.1996.6040219.x","article-title":"An edgewise look at basal epithelial cells: three-dimensional views of the rat prostate, mammary gland and salivary gland","volume":"60","author":"Hayward","year":"1996","journal-title":"Differentiation"},{"key":"10.1016\/j.gene.2026.150131_b0470","unstructured":"https:\/\/www.jax.org\/strain\/033754. [Accessed on 02 January 2026]."},{"key":"10.1016\/j.gene.2026.150131_b0475","unstructured":"https:\/\/www.jax.org\/strain\/033757. [Accessed on 02 January 2026]."},{"key":"10.1016\/j.gene.2026.150131_b0480","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1158\/0008-5472.CAN-14-3280","article-title":"Combined MYC activation and pten loss are sufficient to create genomic instability and lethal metastatic prostate cancer","volume":"76","author":"Hubbard","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0485","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a030411","article-title":"Histopathology of prostate cancer","volume":"7","author":"Humphrey","year":"2017","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.gene.2026.150131_b0490","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1593\/neo.07562","article-title":"Origin of androgen-insensitive poorly differentiated tumors in the transgenic adenocarcinoma of mouse prostate model","volume":"9","author":"Huss","year":"2007","journal-title":"Neoplasia"},{"key":"10.1016\/j.gene.2026.150131_b0495","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.1158\/0008-5472.CAN-12-4213","article-title":"Animal models of human prostate cancer: the consensus report of the New York meeting of the mouse models of human cancers consortium prostate pathology committee","volume":"73","author":"Ittmann","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0500","doi-asserted-by":"crossref","first-page":"e9427","DOI":"10.1371\/journal.pone.0009427","article-title":"MYC overexpression induces prostatic intraepithelial neoplasia and loss of Nkx3.1 in mouse luminal epithelial cells","volume":"5","author":"Iwata","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150131_b0505","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1146\/annurev.genet.30.1.603","article-title":"Tumor suppressor gene mutations in mice","volume":"30","author":"Jacks","year":"1996","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0510","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1101\/gad.943001","article-title":"Analysis of lung tumor initiation and progression using conditional expression of oncogenic K-ras","volume":"15","author":"Jackson","year":"2001","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150131_b0515","article-title":"EZH2 suppression diversifies prostate cancer lineage variant evolution and lacks efficacy in inhibiting disease progression","author":"Jacobi","year":"2025","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0520","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1038\/nrurol.2018.9","article-title":"Clinical implications of PTEN loss in prostate cancer","volume":"15","author":"Jamaspishvili","year":"2018","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0525","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1210\/mend.12.1.0050","article-title":"Human sex hormone-binding globulin gene expression in transgenic mice","volume":"12","author":"J\u00e4nne","year":"1998","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.gene.2026.150131_b0530","doi-asserted-by":"crossref","first-page":"e3949","DOI":"10.1371\/journal.pone.0003949","article-title":"BRAF activation initiates but does not maintain invasive prostate adenocarcinoma","volume":"3","author":"Jeong","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.gene.2026.150131_b0535","doi-asserted-by":"crossref","first-page":"6083","DOI":"10.1158\/0008-5472.CAN-06-4202","article-title":"Murine cell lines derived from Pten null prostate cancer show the critical role of PTEN in hormone refractory prostate cancer development","volume":"67","author":"Jiao","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0540","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1002\/pros.10283","article-title":"Transgenic mouse with high Cre recombinase activity in all prostate lobes, seminal vesicle, and ductus deferens","volume":"57","author":"Jin","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0545","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/s41467-018-08282-8","article-title":"Noninvasive optical activation of Flp recombinase for genetic manipulation in deep mouse brain regions","volume":"10","author":"Jung","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0550","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/pros.10215","article-title":"Pathobiology of autochthonous prostate cancer in a pre-clinical transgenic mouse model","volume":"55","author":"Kaplan-Lefko","year":"2003","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0555","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1126\/science.aay0267","article-title":"Regenerative potential of prostate luminal cells revealed by single-cell analysis","volume":"368","author":"Karthaus","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150131_b0560","doi-asserted-by":"crossref","first-page":"137","DOI":"10.15252\/emmm.201606857","article-title":"Genetically engineered mouse models in oncology research and cancer medicine","volume":"9","author":"Kersten","year":"2017","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.gene.2026.150131_b0565","first-page":"2999","article-title":"Nkx3.1 mutant mice recapitulate early stages of prostate carcinogenesis","volume":"62","author":"Kim","year":"2002","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0570","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/onc.2011.236","article-title":"A mouse model of heterogeneous, c-MYC-initiated prostate cancer with loss of Pten and p53","volume":"31","author":"Kim","year":"2012","journal-title":"Oncogene"},{"key":"10.1016\/j.gene.2026.150131_b0575","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/ng.371","article-title":"Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis","volume":"41","author":"King","year":"2009","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0580","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1073\/pnas.0711711105","article-title":"A causal role for ERG in neoplastic transformation of prostate epithelium","volume":"105","author":"Klezovitch","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0585","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.aah4199","article-title":"Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance","volume":"355","author":"Ku","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150131_b0590","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1038\/s41467-019-12298-z","article-title":"High-fat diet fuels prostate cancer progression by rewiring the metabolome and amplifying the MYC program","volume":"10","author":"Labb\u00e9","year":"2019","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0595","doi-asserted-by":"crossref","first-page":"4492","DOI":"10.1172\/JCI128212","article-title":"Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer","volume":"129","author":"Labrecque","year":"2019","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.gene.2026.150131_b0600","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.celrep.2012.07.004","article-title":"MASTR: a technique for mosaic mutant analysis with spatial and temporal control of recombination using conditional floxed alleles in mice","volume":"2","author":"Lao","year":"2012","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0605","doi-asserted-by":"crossref","first-page":"5581","DOI":"10.1128\/JVI.02609-10","article-title":"Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma","volume":"85","author":"Lee","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.gene.2026.150131_b0610","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.ccell.2016.03.001","article-title":"N-Myc drives neuroendocrine prostate cancer initiated from human prostate epithelial cells","volume":"29","author":"Lee","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0615","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1038\/modpathol.2016.88","article-title":"Analytic validation of a clinical-grade PTEN immunohistochemistry assay in prostate cancer by comparison with PTEN FISH","volume":"29","author":"Lotan","year":"2016","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0620","doi-asserted-by":"crossref","first-page":"65566","DOI":"10.18632\/oncotarget.19217","article-title":"PTEN loss detection in prostate cancer: comparison of PTEN immunohistochemistry and PTEN FISH in a large retrospective prostatectomy cohort","volume":"8","author":"Lotan","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.gene.2026.150131_b0625","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/ng.2650","article-title":"A co-clinical approach identifies mechanisms and potential therapies for androgen deprivation resistance in prostate cancer","volume":"45","author":"Lunardi","year":"2013","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0630","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/(SICI)1526-968X(200002)26:2<154::AID-GENE18>3.0.CO;2-2","article-title":"Prostate specific expression of Cre recombinase in transgenic mice","volume":"26","author":"Maddison","year":"2000","journal-title":"Genesis"},{"key":"10.1016\/j.gene.2026.150131_b0635","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1016\/j.neuron.2015.02.022","article-title":"Transgenic mice for intersectional targeting of neural sensors and effectors with high specificity and performance","volume":"85","author":"Madisen","year":"2015","journal-title":"Neuron"},{"key":"10.1016\/j.gene.2026.150131_b0640","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2024.115064","article-title":"Metabolic reprogramming, sensing, and cancer therapy","volume":"43","author":"Mao","year":"2024","journal-title":"Cell Rep."},{"key":"10.1016\/j.gene.2026.150131_b0645","doi-asserted-by":"crossref","first-page":"11236","DOI":"10.1073\/pnas.91.23.11236","article-title":"Prostate and mammary adenocarcinoma in transgenic mice carrying a rat C3(1) simian virus 40 large tumor antigen fusion gene","volume":"91","author":"Maroulakou","year":"1994","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0650","first-page":"2239","article-title":"A probasin-large T antigen transgenic mouse line develops prostate adenocarcinoma and neuroendocrine carcinoma with metastatic potential","volume":"61","author":"Masumori","year":"2001","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0655","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa2407934","article-title":"Assessment of a polygenic risk score in screening for prostate cancer","volume":"392","author":"McHugh","year":"2025","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.gene.2026.150131_b0660","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1093\/jnci\/djp030","article-title":"Fatty acid synthase: a metabolic enzyme and candidate oncogene in prostate cancer","volume":"101","author":"Migita","year":"2009","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.gene.2026.150131_b0665","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1038\/s41467-020-16030-0","article-title":"Photoactivatable Cre recombinase 3.0 for in vivo mouse applications","volume":"11","author":"Morikawa","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0670","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.ccr.2011.05.006","article-title":"Cell autonomous role of PTEN in regulating castration-resistant prostate cancer growth","volume":"19","author":"Mulholland","year":"2011","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0675","doi-asserted-by":"crossref","unstructured":"Oliveira, D.S., Dzinic, S., Bonfil, A.I., Saliganan, A.D., Sheng, S., Bonfil, R.D., 2016. The mouse prostate: a basic anatomical and histological guideline. Bosn J Basic Med Sci 16, 8-13. 10.17305\/bjbms.2016.917.","DOI":"10.17305\/bjbms.2016.917"},{"key":"10.1016\/j.gene.2026.150131_b0680","doi-asserted-by":"crossref","DOI":"10.3390\/cancers16213685","article-title":"Deciphering the tumor microenvironment in prostate cancer: a focus on the stromal component","volume":"16","author":"Pakula","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.gene.2026.150131_b0685","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41467-023-44210-1","article-title":"Distinct mesenchymal cell states mediate prostate cancer progression","volume":"15","author":"Pakula","year":"2024","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0690","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1146\/annurev.ge.20.120186.002341","article-title":"Germ-line transformation of mice","volume":"20","author":"Palmiter","year":"1986","journal-title":"Annu. Rev. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0695","article-title":"Senescence controls prostatic neoplasia driven by Pten loss","volume":"6","author":"Parisotto","year":"2019","journal-title":"Mol. Cell. Oncol."},{"key":"10.1016\/j.gene.2026.150131_b0700","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1200\/JCO.2013.49.8386","article-title":"TMPRSS2:ERG gene fusion predicts subsequent detection of prostate cancer in patients with high-grade prostatic intraepithelial neoplasia","volume":"32","author":"Park","year":"2014","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.gene.2026.150131_b0705","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1038\/s41585-020-00379-4","article-title":"Targetable gene fusions and aberrations in genitourinary oncology","volume":"17","author":"Pederzoli","year":"2020","journal-title":"Nat. Rev. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0710","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1038\/s41416-022-02085-x","article-title":"Stromal cells in prostate cancer pathobiology: friends or foes?","volume":"128","author":"Pederzoli","year":"2023","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.gene.2026.150131_b0715","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.euo.2024.04.011","article-title":"Prognostic and predictive role of SPOP mutations in prostate cancer: a systematic review and meta-analysis","volume":"7","author":"Pedrani","year":"2024","journal-title":"Eur Urol Oncol"},{"key":"10.1016\/j.gene.2026.150131_b0720","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1126\/science.abf8403","article-title":"Commensal bacteria promote endocrine resistance in prostate cancer through androgen biosynthesis","volume":"374","author":"Pernigoni","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150131_b0725","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1158\/1055-9965.EPI-17-0637","article-title":"MYC overexpression at the protein and mRNA level and cancer outcomes among men treated with radical prostatectomy for prostate cancer","volume":"27","author":"Pettersson","year":"2018","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"10.1016\/j.gene.2026.150131_b0730","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2415308122","article-title":"Comparative transcriptomics reveals a mixed basal, club, and hillock epithelial cell identity in castration-resistant prostate cancer","volume":"122","author":"Pitzen","year":"2025","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0735","first-page":"1","article-title":"Comparative aspects of development and structure in the prostate","volume":"12","author":"Price","year":"1963","journal-title":"Natl. Cancer Inst. Monogr."},{"key":"10.1016\/j.gene.2026.150131_b0740","doi-asserted-by":"crossref","first-page":"7198","DOI":"10.1158\/0008-5472.CAN-14-1490","article-title":"AKT1 and MYC induce distinctive metabolic fingerprints in human prostate cancer","volume":"74","author":"Priolo","year":"2014","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0745","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/modpathol.3880487","article-title":"Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression","volume":"15","author":"Qian","year":"2002","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0750","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1038\/s41467-022-30257-z","article-title":"MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets","volume":"13","author":"Qiu","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0755","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1002\/pros.22490","article-title":"A Hoxb13-driven reverse tetracycline transactivator system for conditional gene expression in the prostate","volume":"72","author":"Rao","year":"2012","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0760","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1073\/pnas.0712021105","article-title":"Temporally controlled ablation of PTEN in adult mouse prostate epithelium generates a model of invasive prostatic adenocarcinoma","volume":"105","author":"Ratnacaram","year":"2008","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0765","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1016\/j.cell.2015.05.001","article-title":"Integrative clinical genomics of advanced prostate cancer","volume":"161","author":"Robinson","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0770","first-page":"707","article-title":"Fatty acid synthase expression defines distinct molecular signatures in prostate cancer","volume":"1","author":"Rossi","year":"2003","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0775","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1093\/jnci\/91.18.1574","article-title":"Clinical significance of alterations of chromosome 8 in high-grade, advanced, nonmetastatic prostate carcinoma","volume":"91","author":"Sato","year":"1999","journal-title":"J. Natl Cancer Inst."},{"key":"10.1016\/j.gene.2026.150131_b0780","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/nm.3646","article-title":"A next-generation dual-recombinase system for time- and host-specific targeting of pancreatic cancer","volume":"20","author":"Sch\u00f6nhuber","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.gene.2026.150131_b0785","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1038\/s41588-018-0142-8","article-title":"Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci","volume":"50","author":"Schumacher","year":"2018","journal-title":"Nat. Genet."},{"key":"10.1016\/j.gene.2026.150131_b0790","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1093\/nar\/26.6.1427","article-title":"Temporally and spatially regulated somatic mutagenesis in mice","volume":"26","author":"Schwenk","year":"1998","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.gene.2026.150131_b0795","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.humpath.2005.11.022","article-title":"Fatty acid synthase gene overexpression and copy number gain in prostate adenocarcinoma","volume":"37","author":"Shah","year":"2006","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0800","doi-asserted-by":"crossref","first-page":"3593","DOI":"10.1158\/0008-5472.CAN-20-3258","article-title":"Mutated SPOP E3 ligase promotes 17\u03b2HSD4 protein degradation to drive androgenesis and prostate cancer progression","volume":"81","author":"Shi","year":"2021","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0805","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1126\/science.278.5335.120","article-title":"Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene","volume":"278","author":"Shibata","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150131_b0810","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1002\/path.2559","article-title":"PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer","volume":"218","author":"Sircar","year":"2009","journal-title":"J. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0815","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1158\/0008-5472.CAN-12-2799","article-title":"Clonal progression of prostate cancers from Gleason grade 3 to grade 4","volume":"73","author":"Sowalsky","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0820","doi-asserted-by":"crossref","unstructured":"Tang, F., Xu, D., Wang, S., Wong, C.K., Martinez-Fundichely, A., Lee, C.J., Cohen, S., Park, J., Hill, C.E., Eng, K., et al. (2022). Chromatin profiles classify castration-resistant prostate cancers suggesting therapeutic targets. Science 376, eabe1505. 10.1126\/science.abe1505.","DOI":"10.1126\/science.abe1505"},{"key":"10.1016\/j.gene.2026.150131_b0825","doi-asserted-by":"crossref","first-page":"7902","DOI":"10.1073\/pnas.1019507108","article-title":"Site-specific integrase-mediated transgenesis in mice via pronuclear injection","volume":"108","author":"Tasic","year":"2011","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0830","first-page":"1177","article-title":"Neoplastic transformation of prostatic and urogenital epithelium by the polyoma virus middle T gene","volume":"149","author":"Tehranian","year":"1996","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0835","unstructured":"The Molecular Taxonomy of Primary Prostate Cancer. (2015). Cell 163, 1011-1025. 10.1016\/j.cell.2015.10.025."},{"key":"10.1016\/j.gene.2026.150131_b0840","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1126\/science.1117679","article-title":"Recurrent fusion of TMPRSS2 and ETS transcription factor genes in prostate cancer","volume":"310","author":"Tomlins","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.gene.2026.150131_b0845","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/nature06024","article-title":"Distinct classes of chromosomal rearrangements create oncogenic ETS gene fusions in prostate cancer","volume":"448","author":"Tomlins","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0850","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1593\/neo.07822","article-title":"Role of the TMPRSS2-ERG gene fusion in prostate cancer","volume":"10","author":"Tomlins","year":"2008","journal-title":"Neoplasia"},{"key":"10.1016\/j.gene.2026.150131_b0855","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.eururo.2009.04.036","article-title":"ETS gene fusions in prostate cancer: from discovery to daily clinical practice","volume":"56","author":"Tomlins","year":"2009","journal-title":"Eur. Urol."},{"key":"10.1016\/j.gene.2026.150131_b0860","doi-asserted-by":"crossref","first-page":"E59","DOI":"10.1371\/journal.pbio.0000059","article-title":"Pten dose dictates cancer progression in the prostate","volume":"1","author":"Trotman","year":"2003","journal-title":"PLoS Biol."},{"key":"10.1016\/j.gene.2026.150131_b0865","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1002\/pros.23003","article-title":"A multicenter study shows PTEN deletion is strongly associated with seminal vesicle involvement and extracapsular extension in localized prostate cancer","volume":"75","author":"Troyer","year":"2015","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0870","first-page":"914","article-title":"Initiation of prostate cancer in mice by Tp53R270H: evidence for an alternative molecular progression","volume":"5","author":"Vinall","year":"2012","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.gene.2026.150131_b0875","doi-asserted-by":"crossref","unstructured":"Vizoso, M., C, E.J.P., Bombardelli, L., van den Broek, B., Krimpenfort, P., Beijersbergen, R.L., Jalink, K., and van Rheenen, J. (2022). A doxycycline- and light-inducible Cre recombinase mouse model for optogenetic genome editing. Nat Commun 13, 6442. 10.1038\/s41467-022-33863-z.","DOI":"10.1038\/s41467-022-33863-z"},{"key":"10.1016\/j.gene.2026.150131_b0880","first-page":"5430","article-title":"PTEN genomic deletion defines favorable prognostic biomarkers in localized prostate cancer: a systematic review and meta-analysis","volume":"8","author":"Wang","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.gene.2026.150131_b0885","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1158\/1541-7786.MCR-25-0251","article-title":"Myeloid-derived suppressor cells: orchestrators of tumor immune evasion and therapeutic vulnerabilities","volume":"23","author":"Wang","year":"2025","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0890","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S1535-6108(03)00215-0","article-title":"Prostate-specific deletion of the murine Pten tumor suppressor gene leads to metastatic prostate cancer","volume":"4","author":"Wang","year":"2003","journal-title":"Cancer Cell"},{"key":"10.1016\/j.gene.2026.150131_b0895","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1073\/pnas.0510652103","article-title":"Pten deletion leads to the expansion of a prostatic stem\/progenitor cell subpopulation and tumor initiation","volume":"103","author":"Wang","year":"2006","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0900","doi-asserted-by":"crossref","first-page":"4765","DOI":"10.1158\/0008-5472.CAN-12-0820","article-title":"B-Raf activation cooperates with PTEN loss to drive c-Myc expression in advanced prostate cancer","volume":"72","author":"Wang","year":"2012","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0905","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nature08361","article-title":"A luminal epithelial stem cell that is a cell of origin for prostate cancer","volume":"461","author":"Wang","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.gene.2026.150131_b0910","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1038\/s41467-020-14296-y","article-title":"Identification of a Zeb1 expressing basal stem cell subpopulation in the prostate","volume":"11","author":"Wang","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0915","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.cell.2013.04.025","article-title":"One-step generation of mice carrying mutations in multiple genes by CRISPR\/Cas-mediated genome engineering","volume":"153","author":"Wang","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.gene.2026.150131_b0920","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1038\/s41467-023-37544-3","article-title":"MYC reshapes CTCF-mediated chromatin architecture in prostate cancer","volume":"14","author":"Wei","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.gene.2026.150131_b0925","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/pros.20200","article-title":"Unopposed c-MYC expression in benign prostatic epithelium causes a cancer phenotype","volume":"63","author":"Williams","year":"2005","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0930","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0925-4773(00)00551-7","article-title":"Generation of a prostate epithelial cell-specific Cre transgenic mouse model for tissue-specific gene ablation","volume":"101","author":"Wu","year":"2001","journal-title":"Mech. Dev."},{"key":"10.1016\/j.gene.2026.150131_b0935","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/(SICI)1097-0045(19970701)32:2<129::AID-PROS8>3.0.CO;2-H","article-title":"Large fragment of the probasin promoter targets high levels of transgene expression to the prostate of transgenic mice","volume":"32","author":"Yan","year":"1997","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0940","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1038\/modpathol.2008.96","article-title":"Absence of TMPRSS2:ERG fusions and PTEN losses in prostate cancer is associated with a favorable outcome","volume":"21","author":"Yoshimoto","year":"2008","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.gene.2026.150131_b0945","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2322203121","article-title":"Single-cell analysis of treatment-resistant prostate cancer: Implications of cell state changes for cell surface antigen-targeted therapies","volume":"121","author":"Zaidi","year":"2024","journal-title":"PNAS"},{"key":"10.1016\/j.gene.2026.150131_b0950","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/1097-0045(20000601)43:4<278::AID-PROS7>3.0.CO;2-4","article-title":"Prostatic neoplasia in transgenic mice with prostate-directed overexpression of the c-myc oncoprotein","volume":"43","author":"Zhang","year":"2000","journal-title":"Prostate"},{"key":"10.1016\/j.gene.2026.150131_b0955","doi-asserted-by":"crossref","first-page":"4698","DOI":"10.1210\/endo.141.12.7837","article-title":"A small composite probasin promoter confers high levels of prostate-specific gene expression through regulation by androgens and glucocorticoids in vitro and in vivo","volume":"141","author":"Zhang","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/j.gene.2026.150131_b0960","doi-asserted-by":"crossref","first-page":"7889","DOI":"10.1158\/0008-5472.CAN-06-0486","article-title":"Synergy of p53 and Rb deficiency in a conditional mouse model for metastatic prostate cancer","volume":"66","author":"Zhou","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.gene.2026.150131_b0965","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1101\/gad.12.15.2424","article-title":"Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization","volume":"12","author":"Zindy","year":"1998","journal-title":"Genes Dev."},{"key":"10.1016\/j.gene.2026.150131_b0970","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1158\/2159-8290.CD-16-1174","article-title":"Transdifferentiation as a Mechanism of Treatment Resistance in a Mouse Model of Castration-Resistant Prostate Cancer","volume":"7","author":"Zou","year":"2017","journal-title":"Cancer Discov."}],"container-title":["Gene"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926001411?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378111926001411?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T01:53:23Z","timestamp":1776218003000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378111926001411"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":194,"alternative-id":["S0378111926001411"],"URL":"https:\/\/doi.org\/10.1016\/j.gene.2026.150131","relation":{},"ISSN":["0378-1119"],"issn-type":[{"value":"0378-1119","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mapping prostate cancer pathobiology: A review of genetically engineered mouse models (GEMMs)","name":"articletitle","label":"Article Title"},{"value":"Gene","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.gene.2026.150131","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"150131"}}